Law360, New York ( February 7, 2014, 4:31 PM EST) -- In a split decision, the Louisiana Supreme Court recently stripped the state of Louisiana of a $258 million jury award against Janssen Pharmaceutica Inc. and Johnson & Johnson in connection with its marketing of the anti-psychotic drug, Risperdal, concluding that the state failed to present evidence establishing a causal link between the defendants' alleged bad acts and the submission of false claims for payment under Louisiana's Medicaid fraud/false claims statute.[1]...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.